RR6
CAS No. 1351758-37-6
RR6( —— )
Catalog No. M23513 CAS No. 1351758-37-6
RR6 acts as a selective, reversible, and competitive vanin inhibitor at nanomolar concentration.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 252 | In Stock |
|
| 10MG | 438 | In Stock |
|
| 25MG | 716 | In Stock |
|
| 50MG | 981 | In Stock |
|
| 100MG | 1332 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRR6
-
NoteResearch use only, not for human use.
-
Brief DescriptionRR6 acts as a selective, reversible, and competitive vanin inhibitor at nanomolar concentration.
-
DescriptionRR6 acts as a selective, reversible, and competitive vanin inhibitor at nanomolar concentration.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorvanin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1351758-37-6
-
Formula Weight293.36
-
Molecular FormulaC16H23NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 100 mg/mL (340.88 mM)
-
SMILESCC(C)(CO)[C@@H](O)C(NCCC(CC1=CC=CC=C1)=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jansen PA et al. Discovery of small molecule vanin inhibitors: new tools to study metabolism and disease. ACS Chem Biol. 2013 Mar 15;8(3):530-4.
molnova catalog
related products
-
Carbaglu
Carglumic acid is an orphan drug used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. This rare genetic disorder results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and cause neurologic problems, cerebral edema, coma, and death.
-
Caracemide
Caracemide inhibits the enzyme ribonucleotide reductase of Escherichia coli. Caracemide can be used in anticancer studies.
-
Urotensin II (Frog)
Urotensin II (Frog)
Cart
sales@molnova.com